Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Efficacy Analysis of Ifosfamide Combined with MVAC to Treat Osteosarcoma
Vol 37, Issue 7, 2023
Abstract
Objective: To explore the curative effect of ifosfamide combined with MVAC (methotrexate, vincristine, adriamycin and cisplatin) to treat osteosarcoma. Methods: Data from patients with osteosarcoma admitted to the Second Hospital of Nanjing and the Fourth Hospital of Hebei Medical University from February 2020 to February 2021 were selected for a retrospective analysis. They were 1:1 divided in the experimental group (EG) and the control group (CG) according to the treatment method applied. The CG was given MVAC, and the EG received MVAC and ifosfamide. Short-term efficacy, inflammatory factors levels and the incidence of adverse reactions between the two groups was assessed. Results: Overall, 120 patients were included in the study. Treatment efficiency in the EG was higher than in the CG (p < 0.05). Tumor necrosis factor-α (TNF-α), c-reactive protein (CRP) and white blood cell (WBC) levels in the EG were overtly lower. Interleukin-10 (IL-10) level was significantly higher compared to the CG (all p < 0.001). Adverse reactions incidence in the EG was lower than in the CG (p < 0.05). Conclusions: Ifosfamide and MVAC combined to treat osteosarcoma show a good safety profile, with improved inflammatory factors levels.
Keywords
References
Supporting Agencies
Copyright (c) 2023 Hao Li, Yiwei Hu, Xidong Zhang
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Medical Genetics, University of Torino Medical School, Italy
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy